2023:Program/Submissions/Liver Cirrhosis - GYLBLU

The following is a mirror of what are publicly available details of submission made at the call for proposal platform, Pretalx. Any changes here may be overwritten by a bot while syncing updates from Pretalx ([1]). Changes are monitored and may be updated into Pretalx if they do not change the context of the submission (i.e. correcting typographical errors).

Title: Liver Cirrhosis

Speakers:

Chidi Chinonso Kingsley

Chidi Chinonso Kingsley is a final year Medical Laboratory Science Student at Imo State University, Owerri, Nigeria, and a passionate researcher with keen interests in Global health advancement, Non-communicable diseases, Bioinformatics, Genetics/Molecular studies, Artificial Intelligence and machine learning. He is a dedicated Wikimedian contributing to Wikipedia, Wikidata and wikimedia Commons projects particularly. He's a lover of music, art and culture, committed to solving problems and making positive societal impact. Author: King ChristLike Title: Chidi Chinonso Kingsley ChristLike.jpg Chidi_Chinonso_Kingsley_ChristLike

Pretalx link

Etherpad link

Room:

Start time:

End time:

Type: Lecture

Track: Research, Science, and Medicine

Submission state: submitted

Duration: 20 minutes

Do not record: false

Presentation language: en

Abstract & description

Abstract

Liver cirrhosis is a chronic liver disease that occurs when healthy liver tissue is replaced with scar tissue. This session captures the pathophysiology, causes, symptoms, diagnosis, and treatment options of liver cirrhosis, including complications that result from cirrhosis. Lastly, preventive measures and lifestyle changes that can help manage the disease will be highlighted.

Description

Liver cirrhosis is a chronic liver disease characterized by the progressive degeneration of liver cells, leading to the formation of scar tissue and impaired liver function. The primary aim of managing liver cirrhosis is to slow down or halt its progression and manage complications such as portal hypertension, ascites, and hepatic encephalopathy. Other objectives of liver cirrhosis management include:

1. Identifying and treating the underlying cause of liver cirrhosis, such as alcohol abuse, viral hepatitis, or non-alcoholic fatty liver disease.

2. Managing symptoms and complications of liver cirrhosis, such as fatigue, itching, abdominal pain, jaundice, and fluid accumulation in the abdomen or legs.

3. Preventing or treating infections, particularly those that can cause liver damage or worsen cirrhosis, such as bacterial peritonitis.

4. Monitoring for liver cancer, which is a common complication of cirrhosis.

5. Encouraging lifestyle changes such as abstaining from alcohol, maintaining a healthy weight, and avoiding hepatotoxic medications.

6. Educating patients and their families on the importance of regular monitoring and follow-up care, as well as strategies to prevent disease progression and manage symptoms.

Further details

Qn. How does your session relate to the event themes: Diversity, Collaboration Future?

Liver Cirrhosis is a disease that cuts across diverse tribes, races and countries. Thus, a conscious collaborative effort is needed for both it's prevention through management to change the existing narrative, thereby promoting global health.

Qn. What is the experience level needed for the audience for your session?

Everyone can participate in this session

Qn. What is the most appropriate format for this session?

• Onsite in Singapore
• Remote online participation, livestreamed
• Remote from a satellite event
• Hybrid with some participants in Singapore and others dialing in remotely
• Pre-recorded and available on demand